Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pecorelli

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Gynecologic and Obstetric Investigation|June 16, 2001
Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancerA D Santin, P L Hermonat, A Ravaggi, et al.
Epidemiology and Infection|April 28, 2017
Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidenceC Signorelli, A Odone, V Ciorba, et al.
International Journal of Cancer|March 1, 1996
Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancersA D Santin, G S Rose, J C Hiserodt, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Caring About Women and Cancer (CAWAC): a European survey of the perspectives and experiences of women with female cancersU Veronesi, S von Kleist, K Redmond, et al.
British Journal of Cancer|June 23, 2004
Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profilingA D Santin, F Zhan, S Bellone, et al.
Progress in Clinical and Biological Research|January 1, 1985
Vincristine, bleomycin, mitomycin C, cisplatin combination chemotherapy as additive treatment to radiotherapy in poor risk patients with squamous cell carcinoma of the uterine cervixJ B Vermorken, M E vd Burg, A J Subandono, et al.
Archives of Virology|May 30, 2006
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patientsA Ravaggi, C Romani, B Pasinetti, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)N S Reed, C Mangioni, H Malmström, et al.
British Journal of Cancer|April 7, 2011
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patientsE Bignotti, M Ragnoli, L Zanotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2005
Integration of new or experimental treatment options and new approaches to clinical trialsM Quinn, J Pfisterer, E Avall-Lundqvist, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Gynecologic and Obstetric Investigation|June 16, 2001
Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancerA D Santin, P L Hermonat, A Ravaggi, et al.
Epidemiology and Infection|April 28, 2017
Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidenceC Signorelli, A Odone, V Ciorba, et al.
International Journal of Cancer|March 1, 1996
Effects of cytokines combined with high-dose gamma irradiation on the expression of major histocompatibility complex molecules and intercellular adhesion molecule-1 in human ovarian cancersA D Santin, G S Rose, J C Hiserodt, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Caring About Women and Cancer (CAWAC): a European survey of the perspectives and experiences of women with female cancersU Veronesi, S von Kleist, K Redmond, et al.
British Journal of Cancer|June 23, 2004
Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profilingA D Santin, F Zhan, S Bellone, et al.
Progress in Clinical and Biological Research|January 1, 1985
Vincristine, bleomycin, mitomycin C, cisplatin combination chemotherapy as additive treatment to radiotherapy in poor risk patients with squamous cell carcinoma of the uterine cervixJ B Vermorken, M E vd Burg, A J Subandono, et al.
Archives of Virology|May 30, 2006
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patientsA Ravaggi, C Romani, B Pasinetti, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2008
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)N S Reed, C Mangioni, H Malmström, et al.
British Journal of Cancer|April 7, 2011
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patientsE Bignotti, M Ragnoli, L Zanotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2005
Integration of new or experimental treatment options and new approaches to clinical trialsM Quinn, J Pfisterer, E Avall-Lundqvist, et al.
Pageof 16